Preimplantation Genetic Screening
6
0
0
2
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
33.3%
2 terminated out of 6 trials
50.0%
-36.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients
Investigating the Cryopreserved Blastocyst's ImplantatiOn Potential After Genetic Screening
The Effects of Miminal Stimulation Protocol on Preimplantation Genetic Screening
Live Birth Rate in Patients With Unexplained Recurrent Pregnancy Loss
The Transition From Blastomere to Trophectoderm Biopsy: Comparing Two PGS Strategies
Cumulative Live Birth Rates in Patients With Repeated Implantation Failure (RIF) Undergoing Preimplantation Genetic Screening (PGS )